Mosliciguat Lowers Pulmonary Vascular Resistance in PH ILD

Evidence Source gap catch-up · Published September 8, 2026 · Discovery September 8, 2026 · Importance 5/5 · Direction Positive Summary Roivant and its Pulmovant subsidiary reported a large, internally consistent randomized Phase II signal for once-daily inhaled mosliciguat in pulmonary hypertension associated with interstitial…